Fifty new jobs have been announced for Dublin today.

Alexion Pharmaceuticals, who are to create the positions over the next year, will establish a global supply chain in Ireland, with the opening of a new facility in the capital. It's part of the firm's expansion plan.

The jobs will be across a range of occupations such as quality assurance, quality control and logistics functions.

The company has its headquarters in Connecticut.

Alexion’s new Irish staff are expected to begin supplying Soliris® (eculizumab) to patients with PNH and aHUS, two severe and life-threatening ultra-rare blood disorders, by the end of 2013. The Irish office will also handle the roll out of new therapies over the next number of eyars.

Today’s announcement is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.

Executive Vice President and Chief Global Operations Officer at Alexion, Stephen Squinto, says the company's come to Ireland because of our skilled and educated workforce.

Jobs minister Richard Bruton said, “Sustaining and building on our strong track record in pharmaceuticals is a key objective of our Action Plan for Jobs, and the past 2 years we have seen some major jobs wins in this sector. Today’s announcement that Alexion is establishing a new operation in Dublin with the creation of 50 jobs is another significant jobs boost for the sector, and I wish all involved every success with their operations here. I am determined that, through continued strong implementation of our plan, we can see further jobs wins in this sector to help create the jobs we need”.

IDA says, with the arrival of Alexion, they have now secured 7 of the top 10 global BioPharma companies.

For further information on those jobs, go to CPL recruitment